Navigation Links
Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765
Date:12/5/2010

rmacyclics.com. To see a slide presentation to be discussed during the call, please go to the Investor Relations Section of our website, under Events & Webcasts: http://ir.pharmacyclics.com/events.cfm and click on "ASH 2010 Conference Call Slides".

About this trialThe Phase Ia is a multicenter study being conducted in collaboration with investigators at leading lymphoma centers including Stanford University, MD Anderson Cancer Center, the University of Chicago, the University of Vermont, Weill Medical College of Cornell University, and the US Oncology Group. The trial is an open-label, dose-escalation study of PCI-32765 in recurrent B cell malignancies treating a minimum of 6 patients per cohort. Fifty six patients were enrolled between March 2009 and September 2010.

In the Phase Ia five dose levels are being explored—1.25, 2.5, 5.0, 8.3 and 12.5 mg/kg/day. Each cycle of treatment consists of 28 consecutive days of once daily dosing followed by a 7-day rest period. Additionally two dose groups at 8.3 mg/kg/day and 560mg have also been explored using a 35-day cycle with no rest period ("continuous dosing" or "CD1 and CD2"). Dose limiting toxicities were evaluated at the end of the first cycle and drug efficacy is evaluated every 2 cycles. Safety is being monitored throughout the trial.

The Phase Ib/II is a multicenter study being conducted in collaboration with investigators at leading lymphoma and leukemia centers including the University of Texas, MD Anderson Cancer Center, Stanford University, Sarah Cannon Research Institute, the University of Vermont, Weill Medical College of Cornell University, the Ohio State University and the US Oncology Group.  This open-label, fixed dose study was designed to evaluate safety and preliminary efficacy in patients with CLL/SLL who received a continuous dose of PCI-32765.  The study is evaluating two patient populations, relaps
'/>"/>

SOURCE Pharmacyclics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
2. Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference
3. Pharmacyclics to Present at Bank of America Merrill Lynch Healthcare Conference and MDB Bright Lights Conference
4. Pharmacyclics to Present at the RBC Capital Markets Healthcare Investor Conference
5. Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results
6. Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7
7. Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology
8. Pharmacyclics to Present at Merriman Curhan Fords Investor Summit 2009
9. Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
10. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
11. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Aug. 28, 2014  Decision Resources Group finds that the ... around $7.7 billion by 2023 in the United ... Germany , Italy , ... and Japan . The biosimilar erosion of ... balanced out by the launch of Eli Lilly,s Cyramza, Taiho ...
(Date:8/28/2014)... 2014 Levi & Korsinsky announces that a ... States District Court for the District of ... Galectin Therapeutics Inc. ("Galectin" or the "Company") (NasdaqCM: GALT) ... For more information, click here: http://zlk.9nl.com/galectin-therapeutics-galt ... Class Period the Company violated federal securities laws by ...
(Date:8/28/2014)... Nonin Medical, Inc., the inventor of finger pulse oximetry ... that the Food and Drug Administration (FDA) has cleared ... use in the United States . ... or kiosk through a USB connector and measures oxygen ... The Model 3231 received EU certification last year. ...
Breaking Medicine Technology:The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2
... 15, 2012 Senior representatives from leading pharmaceutical ... Novartis MIT will meet at the Pharma Qbd Forum in ... to share their expert knowledge on how Quality by Design ... the main points of discussion will be the findings of ...
... Feb. 14, 2012  At a meeting held today, the Directors ... per share. The dividend is payable on March 15, 2012 ... About Sigma-Aldrich :  Sigma-Aldrich ... High Technology company whose biochemical, organic ...
Cached Medicine Technology:Understand the Lessons Learned from the FDA QbD Pilot Programme - Case Study Merck Serono 2
(Date:8/28/2014)... Toronto, Ontario (PRWEB) August 28, 2014 ... and supply company in North America, today announced the ... that makes doing business with Canadian Linen even ... tool allows customers to access account information online and ... new customer portal include the ability to:, ...
(Date:8/28/2014)... Parker Waichman LLP, a national personal ... to ensure that the heroes of 9/11 are never ... WTC victims who developed 9/11-related cancer was reaffirmed by ... (GAO). According to a statement issued by 9/11 ... entitled “World Trade Center Health Program: Approach Used to ...
(Date:8/28/2014)... Watertown, MA (PRWEB) August 28, 2014 ... , is delighted to present its new Kids’ Share, which ... Share will encourage kids (and their parents) to get into ... their very own vegetable share. Each week the Kids’ Share ... fabulous veggies, shares will include activities for kids, recipes from ...
(Date:8/28/2014)... 2014 Clarity PSO , an ... as a federal Patient Safety Organization (PSO) for another ... Healthcare Research and Quality (AHRQ). Clarity PSO will continue ... services following the true intentions of the Patient Safety ... are proud and eager to continue our journey as ...
(Date:8/28/2014)... 2014 (HealthDay News) -- Having greater amounts of yellow ... see distant objects in hazy conditions, a new study ... researchers simulated hazy conditions in order to test the ... pigment (also called macular pigment) in their eyes. ... which represents accumulations of the nutrients lutein and zeaxanthin, ...
Breaking Medicine News(10 mins):Health News:Canadian Linen and Uniform Service Launches New Customer Portal 2Health News:Canadian Linen and Uniform Service Launches New Customer Portal 3Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 2Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 3Health News:Kids Don't Have to Share Their Vegetables, Thanks to Siena Farms, ChopChop Magazine & Chef Ana Sortun 2Health News:Kids Don't Have to Share Their Vegetables, Thanks to Siena Farms, ChopChop Magazine & Chef Ana Sortun 3Health News:Kids Don't Have to Share Their Vegetables, Thanks to Siena Farms, ChopChop Magazine & Chef Ana Sortun 4Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3Health News:Eye Pigment May Help Vision in Hazy Conditions 2
... 18 One year ago today, the,American people ... and outpatient facilities treating wounded soldiers returning,from Iraq ... those,reports, John McCain saw an opportunity to bolster ... blamed the scandal on former,Secretary of Defense Don ...
... Rep. Jason Altmire,(D-PA) will experience the vital and expanding ... of the clinical laboratory facilities,at Magee-Womens Hospital Tuesday, Feb. ... the 5:30 P.M. tour for,Rep. Altmire, who will view ... "Magee-Womens Hospital,s ongoing leadership in improving health care,for ...
... ALAMOS, N.M., Feb. 18 Meat & Livestock ... techniques for,high-speed CT scans of livestock carcasses. Using ... will begin Phase 1 of a,multi-year, 6 phase ... production CT applications include the potential to scan ...
... be,prepared and take action., That,s the advice ... tragedies like the one recently at Northern Illinois ... of K-State,s College of,Human Ecology and associate professor ... Research, Education and Consultation at K-State, or TRECK,Team., ...
... Spanish . , ANN ARBOR, Mich. People taking ... their symptoms during the first few months, but lagging behind ... research from the University of Michigan Health System. , That ... hopelessness even while their condition is improving, which could lead ...
... Feb. 18 Darwin,Professional Underwriters, Inc. (Darwin), ... its lawyers professional liability policy. Limits of ... from one to one hundred attorneys. All,areas ... maintains a particular,focus on plaintiff,s personal injury ...
Cached Medicine News:Health News:Walter Reed Anniversary Exposes More McCain Double Talk 2Health News:Walter Reed Anniversary Exposes More McCain Double Talk 3Health News:Congressman Altmire Tours Women's Health Clinical Laboratory; Learns Vital Role in Patient Care 2Health News:IMTEC to Become Technology Solutions Provider for Meat & Livestock Australia 2Health News:K-State Trauma Researcher Says Being Prepared, Taking Action Are Vital in Preventing Tragedies Like the One at NIU 2Health News:As depression symptoms improve with antidepressants, hopelessness can linger 2Health News:Darwin Introduces Enhancements to its Lawyers Professional Liability Insurance Policy Including Privacy Wrongful Acts and More 2Health News:Darwin Introduces Enhancements to its Lawyers Professional Liability Insurance Policy Including Privacy Wrongful Acts and More 3
... mechanism for speed, stability and durability. ... display modes, multiple units of measure, ... auto print, and GLP/GMP/ISO output including ... clock. Built-in, motor-driven internal calibration ...
TOPLOAD 3200/0.01G, BL3200H. Touch-key external calibration only. Requires calibration weights (either 2000g or 3000g). 120/240V A/C adapter, Lock-down Ring, In-use Protective Cover....
... Portable - Battery Powered (6 size AA ... conversion (g, ct, oz, ozt, GN, dwt, ... Counting and Percent Measure functions, Auto Print. ... Optional AC adapter may be ordered for ...
... BX620S. Digital stability control, analog display ... counting and percent measure functions, auto ... and time data from built-in clock. ... (selectable from 200g to 600g). Built-in ...
Medicine Products: